https://www.selleckchem.com/pr....oducts/Deforolimus.h
9-42.7) of patients with CKD stages 3-5 had newly measured anemia, increasing to 67.7% (95%-CI 67.2-68.2) after five years. The absolute and relative anemia risk increased markedly with higher CKD stages. The adjusted HR of any anemia was 5.42 (95%-CI 5.09-5.77) in patients with CKD stage 5 compared to patients with CKD stage 3a. Patients with newly identified CKD stages 3-5 have a substantial risk of anemia, increasing with higher CKD stages. This study underlines that clinical awareness of anemia risk is important in patients with
Like
Comment
Share
